Drug intelligence / Profile preview

Gentafix 1

Development stage
Unknown
Lead developer
Teknimed
Modality
Small Molecules, Device-based Delivery → Drug Delivery Systems
Administration
Implant
01

Overview

Gentafix 1 is a high viscosity, radiopaque, self-hardening bone cement containing gentamicin, an aminoglycoside antibiotic. It is dedicated to arthroplasty surgery—such as shoulder, hip, and knee procedures—and is used to provide immediate and stable anchorage of implants while delivering local antibiotic therapy to help cure or prevent infections. Gentamicin acts by binding to prokaryotic ribosomes, inhibiting protein synthesis in susceptible bacteria, and exhibiting a broad antibacterial spectrum against most bacteria encountered in orthopedic surgeries. The cement formulation enables optimized long-term release of gentamicin, reducing infection risk. Gentafix 1 is not a systemic pharmaceutical; it is a device-drug combination primarily for orthopaedic use. Developed and manufactured by Teknimed.

Brand names
Gentafix 1Gentafix1Gentafix-1
Other names
Gentafix 1Gentafix1Gentafix-1
02

Targets

23S rRNA (23S ribosomal RNA)CM/OM (Bacterial cytoplasmic and outer membranes)Bacterial RibosomeNadE (Brain-expressed X-linked protein 3)

Beyond the preview

Go deeper on Gentafix 1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gentafix 1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call